Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimal duration of dual antiplatelet therapy after drug-eluting coronary stent placement
2008-005651-24Phase 4Active
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Oct 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of clopidogrel and aspirin in acute coronary syndrome (ACS), stable angina, cardiac ischemia and 2 more, sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Primary composite endpoint of clinical events. Started Oct 2008; status: active.
02
Drugs
clopidogrelaspirin
03
Conditions
acute coronary syndrome (ACS)stable anginacardiac ischemiacoronary arteriosclerosisVasculopathy
Beyond the preview
Go deeper on 2008-005651-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-005651-24.